Human Phenotype Ontology 
Grandparent Node:
expand
Abnormal nervous system physiology (HP:0012638)help
Parent Node:
expand
Abnormality of higher mental function (HP:0011446)help
..Starting node
..expand
Agnosia (HP:0010524)help
Term ID: 10524
Name: Agnosia
Synonym:
Definition: Inability to recognize objects not because of sensory deficit but because of the inability to combine components of sensory impressions into a complete pattern. Thus, agnosia is a neurological condition which results in an inability to know, to name, to identify, and to extract meaning from visual, auditory, or tactile impressions.
Comments:
Reference: HP:0010524
Genes and Diseases:
 
       Child Nodes:
........expandFinger agnosia (HP:0010525) help
........expandAstereognosia (HP:0010527) help
........expandProsopagnosia (HP:0010528) help
........expandVisual agnosia (HP:0030222) help

 Sister Nodes: 
..expandApraxia (HP:0002186) help
..expandCognitive impairment (HP:0100543) help
..expandLanguage impairment (HP:0002463) help
..expandMicrographia (HP:0031908) help
..expandNeurological speech impairment (HP:0002167) help
..expandOptic ataxia (HP:0031868) help
..expandReduced consciousness/confusion (HP:0004372) help
InputHPO IDHPO termDistanceGeneGene id entrezDiseaseIdDiseaseNameDiseaseMIMConceptIDSourceTypical associationHGMD variantsClinVar variantsHGNC IDGeneMIM
 
HPO disease - gene - phenotype typical associations:
HP:0010524HP:0010524Agnosia0GRIN2A CL E G H2903245570Epilepsy, focal, with speech disorder and with or without mental retardation245570C1832814OMIM115774585138253
HP:0010524HP:0010524Agnosia0TREM2 CL E G H542092770ORPHA111017761605086
HP:0010524HP:0010524Agnosia0TYROBP CL E G H73052770ORPHA18512449604142
HP:0010524HP:0010524Agnosia0TYROBP CL E G H7305221770Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy221770C1857316OMIM18512449604142
HP:0010524HP:0030222Visual agnosia1GRIN2A CL E G H2903245570Epilepsy, focal, with speech disorder and with or without mental retardation245570C1832814OMIM115774585138253
HP:0010524HP:0010528Prosopagnosia1GRIN2A CL E G H2903245570Epilepsy, focal, with speech disorder and with or without mental retardation245570C1832814OMIM115774585138253
HP:0010524HP:0010525Finger agnosia1GRIN2A CL E G H2903245570Epilepsy, focal, with speech disorder and with or without mental retardation245570C1832814OMIM115774585138253
HP:0010524HP:0010527Astereognosia1GRIN2A CL E G H2903245570Epilepsy, focal, with speech disorder and with or without mental retardation245570C1832814OMIM115774585138253
HP:0010524HP:0010528Prosopagnosia1TREM2 CL E G H542092770ORPHA111017761605086
HP:0010524HP:0010525Finger agnosia1TREM2 CL E G H542092770ORPHA111017761605086
HP:0010524HP:0010527Astereognosia1TREM2 CL E G H542092770ORPHA111017761605086
HP:0010524HP:0030222Visual agnosia1TREM2 CL E G H542092770ORPHA111017761605086
HP:0010524HP:0010525Finger agnosia1TYROBP CL E G H73052770ORPHA18512449604142
HP:0010524HP:0010527Astereognosia1TYROBP CL E G H73052770ORPHA18512449604142
HP:0010524HP:0030222Visual agnosia1TYROBP CL E G H73052770ORPHA18512449604142
HP:0010524HP:0010528Prosopagnosia1TYROBP CL E G H73052770ORPHA18512449604142
HP:0010524HP:0010527Astereognosia1TYROBP CL E G H7305221770Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy221770C1857316OMIM18512449604142
HP:0010524HP:0030222Visual agnosia1TYROBP CL E G H7305221770Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy221770C1857316OMIM18512449604142
HP:0010524HP:0010528Prosopagnosia1TYROBP CL E G H7305221770Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy221770C1857316OMIM18512449604142
HP:0010524HP:0010525Finger agnosia1TYROBP CL E G H7305221770Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy221770C1857316OMIM18512449604142
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0010524HP:0010524Agnosia0EPCAM CL E G H4072144ORPHA061311529185535
HP:0010524HP:0010524Agnosia0FAN1 CL E G H22909144ORPHA036029170613534
HP:0010524HP:0010524Agnosia0KRAS CL E G H3845144ORPHA04406407190070
HP:0010524HP:0010524Agnosia0MLH1 CL E G H4292144ORPHA048267127120436
HP:0010524HP:0010524Agnosia0MLH3 CL E G H27030144ORPHA018247128604395
HP:0010524HP:0010524Agnosia0MSH2 CL E G H4436144ORPHA063747325609309
HP:0010524HP:0010524Agnosia0MSH6 CL E G H2956144ORPHA077067329600678
HP:0010524HP:0010524Agnosia0PIK3CA CL E G H5290144ORPHA09758975171834
HP:0010524HP:0010524Agnosia0PMS1 CL E G H5378144ORPHA0969121600258
HP:0010524HP:0010524Agnosia0PMS2 CL E G H5395144ORPHA043469122600259
HP:0010524HP:0010524Agnosia0PSEN1 CL E G H5663607822Alzheimer disease, type 3607822C1843013OMIM04529508104311
HP:0010524HP:0010524Agnosia0TGFBR2 CL E G H7048144ORPHA084211773190182
HP:0010524HP:0010525Finger agnosia1EPCAM CL E G H4072144ORPHA061311529185535
HP:0010524HP:0010527Astereognosia1EPCAM CL E G H4072144ORPHA061311529185535
HP:0010524HP:0030222Visual agnosia1EPCAM CL E G H4072144ORPHA061311529185535
HP:0010524HP:0010528Prosopagnosia1EPCAM CL E G H4072144ORPHA061311529185535
HP:0010524HP:0010527Astereognosia1FAN1 CL E G H22909144ORPHA036029170613534
HP:0010524HP:0030222Visual agnosia1FAN1 CL E G H22909144ORPHA036029170613534
HP:0010524HP:0010528Prosopagnosia1FAN1 CL E G H22909144ORPHA036029170613534
HP:0010524HP:0010525Finger agnosia1FAN1 CL E G H22909144ORPHA036029170613534
HP:0010524HP:0030222Visual agnosia1KRAS CL E G H3845144ORPHA04406407190070
HP:0010524HP:0010528Prosopagnosia1KRAS CL E G H3845144ORPHA04406407190070
HP:0010524HP:0010525Finger agnosia1KRAS CL E G H3845144ORPHA04406407190070
HP:0010524HP:0010527Astereognosia1KRAS CL E G H3845144ORPHA04406407190070
HP:0010524HP:0010528Prosopagnosia1MLH1 CL E G H4292144ORPHA048267127120436
HP:0010524HP:0010525Finger agnosia1MLH1 CL E G H4292144ORPHA048267127120436
HP:0010524HP:0010527Astereognosia1MLH1 CL E G H4292144ORPHA048267127120436
HP:0010524HP:0030222Visual agnosia1MLH1 CL E G H4292144ORPHA048267127120436
HP:0010524HP:0010525Finger agnosia1MLH3 CL E G H27030144ORPHA018247128604395
HP:0010524HP:0010527Astereognosia1MLH3 CL E G H27030144ORPHA018247128604395
HP:0010524HP:0030222Visual agnosia1MLH3 CL E G H27030144ORPHA018247128604395
HP:0010524HP:0010528Prosopagnosia1MLH3 CL E G H27030144ORPHA018247128604395
HP:0010524HP:0010527Astereognosia1MSH2 CL E G H4436144ORPHA063747325609309
HP:0010524HP:0030222Visual agnosia1MSH2 CL E G H4436144ORPHA063747325609309
HP:0010524HP:0010528Prosopagnosia1MSH2 CL E G H4436144ORPHA063747325609309
HP:0010524HP:0010525Finger agnosia1MSH2 CL E G H4436144ORPHA063747325609309
HP:0010524HP:0030222Visual agnosia1MSH6 CL E G H2956144ORPHA077067329600678
HP:0010524HP:0010528Prosopagnosia1MSH6 CL E G H2956144ORPHA077067329600678
HP:0010524HP:0010525Finger agnosia1MSH6 CL E G H2956144ORPHA077067329600678
HP:0010524HP:0010527Astereognosia1MSH6 CL E G H2956144ORPHA077067329600678
HP:0010524HP:0010528Prosopagnosia1PIK3CA CL E G H5290144ORPHA09758975171834
HP:0010524HP:0010525Finger agnosia1PIK3CA CL E G H5290144ORPHA09758975171834
HP:0010524HP:0010527Astereognosia1PIK3CA CL E G H5290144ORPHA09758975171834
HP:0010524HP:0030222Visual agnosia1PIK3CA CL E G H5290144ORPHA09758975171834
HP:0010524HP:0010525Finger agnosia1PMS1 CL E G H5378144ORPHA0969121600258
HP:0010524HP:0010527Astereognosia1PMS1 CL E G H5378144ORPHA0969121600258
HP:0010524HP:0030222Visual agnosia1PMS1 CL E G H5378144ORPHA0969121600258
HP:0010524HP:0010528Prosopagnosia1PMS1 CL E G H5378144ORPHA0969121600258
HP:0010524HP:0010527Astereognosia1PMS2 CL E G H5395144ORPHA043469122600259
HP:0010524HP:0030222Visual agnosia1PMS2 CL E G H5395144ORPHA043469122600259
HP:0010524HP:0010528Prosopagnosia1PMS2 CL E G H5395144ORPHA043469122600259
HP:0010524HP:0010525Finger agnosia1PMS2 CL E G H5395144ORPHA043469122600259
HP:0010524HP:0010528Prosopagnosia1PSEN1 CL E G H5663607822Alzheimer disease, type 3607822C1843013OMIM04529508104311
HP:0010524HP:0010525Finger agnosia1PSEN1 CL E G H5663607822Alzheimer disease, type 3607822C1843013OMIM04529508104311
HP:0010524HP:0010527Astereognosia1PSEN1 CL E G H5663607822Alzheimer disease, type 3607822C1843013OMIM04529508104311
HP:0010524HP:0030222Visual agnosia1PSEN1 CL E G H5663607822Alzheimer disease, type 3607822C1843013OMIM04529508104311
HP:0010524HP:0030222Visual agnosia1TGFBR2 CL E G H7048144ORPHA084211773190182
HP:0010524HP:0010528Prosopagnosia1TGFBR2 CL E G H7048144ORPHA084211773190182
HP:0010524HP:0010525Finger agnosia1TGFBR2 CL E G H7048144ORPHA084211773190182
HP:0010524HP:0010527Astereognosia1TGFBR2 CL E G H7048144ORPHA084211773190182


Genes (26) :ABCA7 APP ATP6AP2 C9ORF72 CHMP2B EPCAM FAN1 GRIN2A GRN KRAS MAPT MLH1 MLH3 MSH2 MSH6 PIK3CA PMS1 PMS2 PSEN1 PSEN2 SORL1 TGFBR2 TMEM106B TOMM40 TREM2 TYROBP

Diseases (8) :144 245570 607822 2770 221770 1020 300423 100069
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is August 2021 release.